日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lifestyle shapes preclinical social and microglial deficits in an Alzheimer's disease mouse model

生活方式影响阿尔茨海默病小鼠模型的临床前社交和微胶质细胞缺陷

Ehret, Fanny; Doludda, Birte; Liu, Hang; Nexhipi, Sindi; Huang, Hao; Rost, Fabian; Overall, Rupert W; Barde, Warsha; Rünker, Annette E; Sieweke, Michael; Dahl, Andreas; Schmidt, Mirko H H; Kempermann, Gerd

Longitudinal Changes of Fundus Autofluorescence and Correlation With Visual Acuity in ABCA4-Associated Stargardt Disease

ABCA4相关Stargardt病患者眼底自发荧光纵向变化及其与视力的相关性

Ibukun, Folahan; Strauss, Rupert W; Rustam, Zainab; Khan, Muhammad Jehanzeb; Cideciyan, Artur V; Birch, David G; Ho, Alexander; Sunness, Janet S; Audo, Isabelle S; Michaelides, Michel; Zrenner, Eberhart; Traboulsi, Elias I; Bernstein, Paul; Sadda, SriniVas; Ip, Michael S; West, Sheila; Kong, Xiangrong

Implementing a model of integrated CKD management between primary and secondary care

在初级和二级医疗机构之间实施慢性肾脏病综合管理模式

Jones, Philippa; O'Keeffe, Hannah; Major, Rupert W; Ritchie, James; Sanganee, Nil; Sinha, Smeeta; Burton, James O

Efficacy and safety of the interleukin-10-fragment F8 fusion protein PF-06687234 as add-on therapy to infliximab in patients with active ulcerative colitis: a randomized, phase IIa clinical trial

白细胞介素-10片段F8融合蛋白PF-06687234作为英夫利昔单抗辅助疗法治疗活动性溃疡性结肠炎患者的疗效和安全性:一项随机IIa期临床试验

Schreiber, Stefan; Danese, Silvio; Vermeire, Séverine; Leong, Rupert W; Pradhan, Vivek; Singh, Ravi Shankar P; Yu, Dahong; Messing, Dean; Neubert, Hendrik; Palandra, Joe; Tehlirian, Christopher; Gale, Jeremy D

Vedolizumab in inflammatory bowel disease: pharmacokinetics and the role of immunomodulator co-therapy

维多珠单抗在炎症性肠病中的应用:药代动力学及免疫调节剂联合治疗的作用

Pudipeddi, Aviv; Chaemsupaphan, Thanaboon; Arzivian, Arteen; Kim, Yong-Sul; Paramsothy, Sudarshan; Kariyawasam, Viraj; Leong, Rupert W

An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease

关于炎症性肠病临床试验中皮质类固醇合理使用的国际共识

Hanžel, Jurij; Solitano, Virginia; Vuyyuru, Sudheer Kumar; Panaccione, Remo; Sands, Bruce E; Peyrin-Biroulet, Laurent; Danese, Silvio; D'Haens, Geert R; Atreya, Raja; Allez, Matthieu; Bernstein, Charles N; Bossuyt, Peter; Bressler, Brian; Bryant, Robert V; Cohen, Benjamin L; Colombel, Jean-Frederic; D'Amico, Ferdinando; Dignass, Axel; Dubinsky, Marla; Fleshner, Phillip; Gearry, Richard B; Hanauer, Stephen B; Hart, Ailsa L; Kayal, Maia; Kucharzik, Torsten; Lakatos, Peter L; Louis, Edouard; Magro, Fernando; Narula, Neeraj; Leong, Rupert W; Panés, Julián; Raine, Tim; Ran, Zhihua; Regueiro, Miguel D; Reinisch, Walter; Singh, Siddharth; Steinhart, A Hillary; Travis, Simon; Ungaro, Ryan C; van der Woude, C Janneke; Yamamoto, Takayuki; Ahuja, Vineet; Rubin, David T; Dulai, Parambir S; Cornfield, Linda J; Hogan, Malcolm; Sandborn, William J; Feagan, Brian G; Jairath, Vipul; Ma, Christopher

Meta-Analysis: Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease

荟萃分析:静脉注射与皮下注射英夫利昔单抗治疗炎症性肠病

Chetwood, John David; Arzivian, Arteen; Tran, Yvonne; Paramsothy, Sudarshan; Leong, Rupert W

Clinical Trial: Association Between Early Disease Clearance and Long-Term Outcomes-4-Year Results From the Phase 3 UNIFI Study of Ustekinumab in Ulcerative Colitis

临床试验:早期疾病清除与长期疗效之间的关联——乌司奴单抗治疗溃疡性结肠炎的3期UNIFI研究的4年结果

Danese, Silvio; Leong, Rupert W; Sands, Bruce E; Ma, Tony; Marano, Colleen; Peyrin-Biroulet, Laurent

Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases

关于在开始使用先进疗法治疗炎症性肠病之前进行评估和疫苗接种的共识声明

Leong, Rupert W; Sakiris, Anthony; Arzivian, Arteen; Chetwood, John David; Chaemsupaphan, Thanaboon; Sparrow, Miles P; Kamm, Michael A; Kariayawasam, Viraj

Vedolizumab serum trough concentrations with and without thiopurines in ulcerative colitis: The prospective VIEWS pharmacokinetics study

维多珠单抗血清谷浓度在溃疡性结肠炎患者中联合或不联合硫嘌呤治疗的影响:前瞻性VIEWS药代动力学研究

Chaemsupaphan, Thanaboon; Pudipeddi, Aviv; Lin, Hui-Yu; Paramsothy, Sudarshan; Kariyawasam, Viraj C; Kermeen, Melissa; Leong, Rupert W